首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 醫療設備 > 整形外科 > 歐洲的骨移植替代物產品市場
產業/市場分類
醫療設備 (4528)
內視鏡檢查設備 (158)
分子呈像/呈影劑 (28)
心血管設備 (335)
可拋式醫學設備 (76)
核子醫學 (80)
病患監測 (382)
眼科設備 (102)
傷口護理 (159)
超音波 (54)
齒科設備 (174)
導管 (232)
整形外科 (335)
醫學影像診斷 (414)
體外診斷設備 (476)
CT/MRI/X光 (172)
e保健 (321)
市場調查報告書

歐洲的骨移植替代物產品市場

European Markets for Bone Graft Substitute Products for Spinal Fusion

出版商 Medtech Insight
出版日期 2011年11月 商品編碼 226967
內容資訊 英文 112 Pages
價格
US $ 4850 PDF by E-mail (Single User License)


歐洲的骨移植替代物產品市場 是由出版商Medtech Insight在2011年11月所出版的。 這份英文市場調查報告書包含112 Pages 價格從美金4850起跳。

簡介

2010年,歐洲的骨移植替代物產品市場約1億1,770萬美元的規模。該市場預計此後將以17.3%的年平均成長率成長,2016年預計將達到4億6,170萬美元的規模。

本報告提供歐洲的骨移植替代物市場趨勢相關調查分析,脊椎疾病種類與概要,主要產品及企業簡介,主要國家·主要產品的市場規模實際成果預測(∼2016年),主要國家的供應商的市場佔有率實際成果(2010年)等彙整資料,為您概述為以下內容。

摘要整理

第1章 臨床概要

  • 脊椎結構
    • 脊椎骨
    • 脊椎管
  • 主要的脊椎疾病
    • 椎間盤突出
    • 退化性椎間盤病變
    • 僵直性脊椎炎
  • 骨質疏鬆症
  • 脊椎退化性關節炎
  • 脊椎彎曲
    • 脊椎側彎
    • 脊椎後彎症·脊椎前彎症
      • 關節炎
        • 骨性關節炎
        • 風濕性關節炎
      • 椎間滑脫
      • 狹窄症
      • 脊椎腫瘤
      • 外傷性脊椎損傷
      • 脊椎骨折

    第2章 歐洲的去礦物質骨基質·人工骨移植物市場

    • 骨移植片的特徵
    • 去礦物質骨基質
      • 主要的去礦物質骨基質產品
        • DePuy/Johnson & Johnson
        • Integra LifeSciences
        • Medtronic
        • Scient'x/Alphatec Spine
        • Smith & Nephew
        • Wright Medical Technology/Wright Medical Group
        • Zimmer
    • 人工骨移植物
      • 主要的人工骨移植物產品
        • Biomet
        • DePuy/Johnson & Johnson
        • Graftys
        • Integra LifeSciences
        • LDR Medical/LDR Holding
        • Medtronic
        • Smith & Nephew
        • Synthes
        • Wright Medical Technology/Wright Medical Group
        • Zimmer
    • 市場分析
    • 競爭分析

    第3章 歐洲的脊椎融合用基因工程人骨形成蛋白產品市場

    • 臨床概要
    • 產品
      • InductOs
      • Opgenra
    • 市場分析
    • 競爭分析

    第4章 企業簡介

    • DePuy Spine, Inc./Johnson & Johnson
    • Graftys SA
    • Integra LifeSciences Corporation
    • LDR Medical/LDR Holding
    • Medtronic, Inc.
    • Scient'x SA/Alphatec Holdings, Inc.
    • Smith & Nephew PLC
    • Synthes, Inc.
    • Wright Medical Technology, Inc./Wright Medical Group
    • Zimmer Holdings, Inc.

    附錄

  • 目錄

    Abstract

    The European market for bone graft substitute products for spinal fusion is projected to experience significant growth over the next half-decade due to a number of factors, particularly an increased prevalence of degenerative disc disease. This new report from Medtech Insight/Elsevier Business Intelligence provides market forecasts and analysis of the European market for bone graft substitute products including bone morphogenetic proteins, demineralized bone matrix, and synthetic bone graft substitutes.

    In 2010, the value of the European market for bone graft substitute products for spinal fusion totaled approximately $177.1 million; during the forecast period covered by this report, this market is projected to grow at a compound annual rate of 17.3%, reaching an estimated $461.7 million in the year 2016.

    This newly published report from Medtech Insight includes a clinical overview of the various bone graft substitutes in use in Europe, a review of the leading drivers and limiters of the European bone graft substitutes products market, and an analysis of the leading competitors and their individual market shares. This is the second in a two-part series of reports on the European market for spinal fusion products.

    Methodology

    Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

    Table of Contents

    EXECUTIVE SUMMARY

    • i. Clinical Overview
    • ii. Demineralized Bone Matrix
      • a. Market Forecast
    • iii. Synthetic Bone Graft Substitutes
      • a. Market Forecast
    • iv. Bone Morphogenetic Proteins
      • a. Market Forecast
    • v. Combined Market Analysis
    • vi. Methodology
    • Exhibit ES-1: Europe, Bone Graft Substitute Products for Spinal Fusion, Combined Market Forecast, 2010-2016

    1.1 Spinal Anatomy

    • 1.1.1 Vertebrae
    • 1.1.2 Spinal Canal

    1.2 Selected Spinal Disorders

    • 1.2.1 Disc Herniation
    • 1.2.2 Degenerative Disc Disease
      • 1.2.2.1 Arthritis
        • 1.2.2.1.1 Osteoarthritis
        • 1.2.2.1.2 Rheumatoid Arthritis
        • 1.2.2.1.3 Ankylosing Spondylitis
      • 1.2.2.2 Osteoporosis
      • 1.2.2.3 Spondylosis
    • 1.2.3 Abnormal Curvature of the Spine
      • 1.2.3.1 Scoliosis
      • 1.2.3.2 Kyphosis and Lordosis
    • 1.2.4 Spondylolisthesis
    • 1.2.5 Stenosis
    • 1.2.6 Spinal Tumors
    • 1.2.7 Traumatic Spinal Injuries
    • 1.2.8 Vertebral Fractures
    • Exhibit 1-1: Lateral View of the Spinal Column
    • Exhibit 1-2: Axial and Lateral Views of the Thoracic Vertebrae
    • Exhibit 1-3: Axial and Lateral Views of the Lumbar Vertebrae
    • Exhibit 1-4: Stages of Disc Herniation
    • Exhibit 1-5: Common Degenerative Spinal Disorders
    • Exhibit 1-6: Lumbar and Thoracic Scoliosis
    • Exhibit 1-7: A Kyphotic versus a Normal Spine
    • Exhibit 1-8: A Lordotic versus a Normal Spine
    • Exhibit 1-9: A Healthy Cervical Spine Compared with Spinal Stenosis and Disc Herniation

    2. THE EUROPEAN MARKET FOR DEMINERALIZED BONE MATRIX AND SYNTHETIC BONE GRAFT SUBSTITUTES

    • 2.1 Bone Graft Characteristics
    • 2.2 Demineralized Bone Matrix
      • 2.2.1 Selected Demineralized Bone Matrix Products
        • 2.2.1.1 DePuy/Johnson & Johnson
        • 2.2.1.2 Integra LifeSciences
        • 2.2.1.3 Medtronic
        • 2.2.1.4 Scient'x/Alphatec Spine
        • 2.2.1.5 Smith & Nephew
        • 2.2.1.6 Wright Medical Technology/Wright Medical Group
        • 2.2.1.7 Zimmer
    • 2.3 Synthetic Bone Graft Substitutes
      • 2.3.1 Selected Synthetic Bone Graft Substitute Products
        • 2.3.1.1 Biomet
        • 2.3.1.2 DePuy/Johnson & Johnson
        • 2.3.1.3 Graftys
        • 2.3.1.4 Integra LifeSciences
        • 2.3.1.5 LDR Medical/LDR Holding
        • 2.3.1.6 Medtronic
        • 2.3.1.7 Smith & Nephew
        • 2.3.1.8 Synthes
        • 2.3.1.9 Wright Medical Technology/Wright Medical Group
        • 2.3.1.10 Zimmer
    • 2.4 Market Analysis
    • 2.5 Competitive Analysis
    • Exhibit 2-1: 2011, Selected Demineralized Bone Matrix Products
    • Exhibit 2-2: 2011, Selected Synthetic Bone Graft Substitute Products
    • Exhibit 2-3: Europe, Bone Graft Substitutes, Market Forecast, 2010-2016
    • Exhibit 2-4: France, Bone Graft Substitutes, Market Forecast, 2010-2016
    • Exhibit 2-5: Germany, Bone Graft Substitutes, Market Forecast, 2010-2016
    • Exhibit 2-6: Italy, Bone Graft Substitutes, Market Forecast, 2010-2016
    • Exhibit 2-7: Spain, Bone Graft Substitutes, Market Forecast, 2010-2016
    • Exhibit 2-8: United Kingdom, Bone Graft Substitutes, Market Forecast, 2010-2016
    • Exhibit 2-9: Benelux, Bone Graft Substitutes, Market Forecast, 2010-2016
    • Exhibit 2-10: Nordic Countries, Bone Graft Substitutes, Market Forecast, 2010-2016
    • Exhibit 2-11: Rest of Europe, Bone Graft Substitutes, Market Forecast, 2010-2016
    • Exhibit 2-12: 2010, Europe, Demineralized Bone Matrix Products Market, Share by Supplier
    • Exhibit 2-13: 2010, France, Demineralized Bone Matrix Products Market, Share by Supplier
    • Exhibit 2-14: 2010, Germany, Demineralized Bone Matrix Products Market, Share by Supplier
    • Exhibit 2-15: 2010, Italy, Demineralized Bone Matrix Products Market, Share by Supplier
    • Exhibit 2-16: 2010, Spain, Demineralized Bone Matrix Products Market, Share by Supplier
    • Exhibit 2-17: 2010, United Kingdom, Demineralized Bone Matrix Products Market, Share by Supplier
    • Exhibit 2-18: 2010, Benelux, Demineralized Bone Matrix Products Market, Share by Supplier
    • Exhibit 2-19: 2010, Nordic Countries, Demineralized Bone Matrix Products Market, Share by Supplier
    • Exhibit 2-20: 2010, Rest of Europe, Demineralized Bone Matrix Products Market, Share by Supplier
    • Exhibit 2-21: 2010, Europe, Synthetic Bone Graft Substitutes Market, Share by Supplier
    • Exhibit 2-22: 2010, France, Synthetic Bone Graft Substitutes Market, Share by Supplier
    • Exhibit 2-23: 2010, Germany, Synthetic Bone Graft Substitutes Market, Share by Supplier
    • Exhibit 2-24: 2010, Italy, Synthetic Bone Graft Substitutes Market, Share by Supplier
    • Exhibit 2-25: 2010, Spain, Synthetic Bone Graft Substitutes Market, Share by Supplier
    • Exhibit 2-26: 2010, United Kingdom, Synthetic Bone Graft Substitutes Market, Share by Supplier
    • Exhibit 2-27: 2010, Benelux, Synthetic Bone Graft Substitutes Market, Share by Supplier
    • Exhibit 2-28: 2010, Nordic Countries, Synthetic Bone Graft Substitutes Market, Share by Supplier
    • Exhibit 2-29: 2010, Rest of Europe, Synthetic Bone Graft Substitutes Market, Share by Supplier

    3. THE EUROPEAN MARKET FOR RECOMBINANT BONE MORPHOGENETIC PROTEIN PRODUCTS FOR SPINAL FUSION

    • 3.1 Clinical Overview
    • 3.2 Products
      • 3.2.1 InductOs
      • 3.2.2 Opgenra
    • 3.3 Market Analysis
    • 3.4 Competitive Analysis
    • Exhibit 3-1: Selected Bone Morphogenetic Proteins
    • Exhibit 3-2: 2011, Selected Recombinant Bone Morphogenetic Protein Products for Spinal Fusion
    • Exhibit 3-3: Europe, Bone Morphogenetic Protein Products, Market Forecast, 2010-2016
    • Exhibit 3-4: France, Bone Morphogenetic Protein Products, Market Forecast, 2010-2016
    • Exhibit 3-5: Germany, Bone Morphogenetic Protein Products, Market Forecast, 2010-2016
    • Exhibit 3-6: Italy, Bone Morphogenetic Protein Products, Market Forecast, 2010-2016
    • Exhibit 3-7: Spain, Bone Morphogenetic Protein Products, Market Forecast, 2010-2016
    • Exhibit 3-8: United Kingdom, Bone Morphogenetic Protein Products, Market Forecast, 2010-2016
    • Exhibit 3-9: Benelux, Bone Morphogenetic Protein Products, Market Forecast, 2010-2016
    • Exhibit 3-10: Nordic Countries, Bone Morphogenetic Protein Products, Market Forecast, 2010-2016
    • Exhibit 3-11: Rest of Europe, Bone Morphogenetic Protein Products, Market Forecast, 2010-2016
    • Exhibit 3-12: 2010, Europe, Bone Morphogenetic Protein Products Market, By Country
    • 4.1 DePuy Spine, Inc./Johnson & Johnson
    • 4.2 Graftys SA
    • 4.3 Integra LifeSciences Corporation
    • 4.4 LDR Medical/LDR Holding
    • 4.5 Medtronic, Inc.
    • 4.6 Scient'x SA/Alphatec Holdings, Inc.
    • 4.7 Smith & Nephew PLC
    • 4.8 Synthes, Inc.
    • 4.9 Wright Medical Technology, Inc./Wright Medical Group
    • 4.10 Zimmer Holdings, Inc.

    APPENDIX: COMPANY LISTING

    Back to Top